Michael Singer

Michael Singer is the current Chief Scientific Officer at Cartesian Therapeutics. Michael has held this position since 2020. Prior to that, they were with Anodyne Nanotech, Inc. from 2019-2020, iVexSol, Inc. from 2018-2019, Within Health from 2016-2018, and BioPorto Diagnostics A/S from 2015-2016. Singer has also been with Pykus Therapeutics, Yale University, and Cartesian Therapeutics in the past. Most recently, they were on the Board of Advisors for Medumo from January 2016 to December 2019.

Michael Singer has a BS, MD, and PhD in Biology, Medicine, and Neuroscience from Yale University. Michael did an Internship/Residency in Internal Medicine and Ophthalmology at Harvard Medical School. Michael is certified by the Commonwealth of Massachusetts in Medical License and by the USPTO in Registered Patent Agent.

Their manager is Murat Kalayoglu, President & CEO. Michael Singer works with Metin Kurtoglu - COO, Miloš Miljković - Chief Medical Officer, and Yi Zhang - Senior Director, Technology.